Delivery Order SPE2DB25D3108-SPE2DB25FPDKM
Award Date 7/22/25
Potential Completion Date 7/23/25
Potential Value $6.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets in quantities of 7 units, valued at $8,696.28. This firm fixed-price delivery order, which was not set-aside, was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order valued at $6,308.10 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Orilissa 150 mg tablets (7-count packaging). This is a firm fixed-price, non-set-aside contract with a completion date of July 21, 2025, and performance in Conshohocken, Pennsylvania. Orilissa is an endometriosis treatment medication, representing the type of specialized pharmaceutical product that AmerisourceBergen routinely supplies to federal...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,290.82, is for the delivery of Orilissa 150 mg tablets. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
- This federal contract award, valued at $4,377.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Orilissa 150 mg tablets and has a completion date of December 10, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,383.04, is for the delivery of the drug Orilissa 150 mg tablet. It is a firm fixed-price delivery order contract with a completion date of May 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $1,355.10 delivery order to Amerisourcebergen Drug Corporation for the supply of 150 mg Orilissa tablets. Under this firm fixed price contract, Amerisourcebergen will deliver seven bottles of the prescription drug to a facility in Conshohocken, Pennsylvania by July 3, 2023 to support the DLA's medical supply needs. As a top pharmaceutical distributor, Amerisourcebergen routinely fulfills delivery orders under the DLA's Prime Vendor program on behalf of...
- This federal contract award, valued at $4,600.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Orilissa 150 mg tablets, a medication used in the treatment of endometriosis, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of March 4, 2024. This award is part of a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,779.34 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for 14 tablets of the 200mg Orilissa drug. The order is for product delivery to a location in Conshohocken, Pennsylvania by October 12, 2023. No set-aside designation was applied to this order, which is being fulfilled under the parent company Amerisourcebergen's corporate office. The Defense Logistics Agency functions include procuring...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order (SPE2DB20D2001|SPE2DB23FM70E) valued at $13,309.86 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Orilissa 150 mg tablets with an ultimate completion date of August 25, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,406.31 firm fixed-price delivery order is for the supply of the prescription medication Orilissa 200 mg tablets. The contract has an ultimate completion date of August 13, 2024. While no set-aside designation is mentioned, Amerisourcebergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a...